All In Biotech

NDA 019872 · Kenvue Brands

Tylenol

Acetaminophen · Oral

Last checked: Nov 20, 2026Latest source record: Jan 16, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1994

Jun 8, 1994

Approved uses

1

Original approval plus efficacy supplements

Registered trials

1,695

325 Phase 3, 144 recruiting

FAERS reports

268,179

228,491 serious, 51,202 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Nov 13, 2024.

Uses temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache premenstrual and menstrual cramps the common cold headache toothache temporarily reduces fever

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jun 8, 1994 Original approval · Type 3 - New Dosage Form
2 products under this application
  • TYLENOL · ACETAMINOPHEN 650MG · TABLET, EXTENDED RELEASE, ORAL · Over-the-counter
  • TYLENOL · ACETAMINOPHEN 650MG · TABLET, EXTENDED RELEASE, ORAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Acetaminophen" as an intervention, any sponsor and status, largest first.

All 1,695 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • off label use24,108
  • fatigue21,605
  • drug ineffective20,037
  • pain19,054
  • nausea18,843
  • headache17,716
  • toxicity to various agents16,820
  • dyspnoea15,471
  • vomiting14,962
  • arthralgia14,927
  • pyrexia14,876
  • diarrhoea14,262

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20042,587
20052,683
20063,149
20072,550
20083,851
20092,960
20103,783
20118,051
20128,030
20133,362
20144,020
20156,241
20168,978
20178,260
201810,004
201913,343
202020,343
202120,681
202227,877
202328,724
202429,377
202529,017
202620,297

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 2,634 on PubMed

Sponsor: Kenvue Brands

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.